Harmony Biosciences Holdings, Inc. (HRMY)
38.55
+0.68
(+1.80%)
USD |
NASDAQ |
Jan 09, 16:00
38.56
+0.01
(+0.03%)
After-Hours: 20:00
Harmony Biosciences Holdings Shareholders Equity (Quarterly): 835.12M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Lifecore Biomedical, Inc. | 36.79M |
| West Pharmaceutical Services, Inc. | 3.052B |
| Liquidia Corp. | 22.05M |
| Castle Biosciences, Inc. | 467.05M |
| Moderna, Inc. | 9.33B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.208B |
| Total Liabilities (Quarterly) | 373.10M |
| Debt to Equity Ratio | 0.2719 |
| Current Ratio | 3.755 |
| Net Debt Paydown Yield | -0.10% |